Physician profile
Daniel Karl Rockey
NPI 1427080084
$612.37
in general payments reported to CMS, 2019-2025
9 companies · $48.63 in 2025
The $48.63 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $16.69 · 2021: $135 · 2022: $22.23 · 2023: $39.12 · 2024: $147 · 2025: $48.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $131.71 | 2019 | |
| Bard Peripheral Vascular, INC. | $117.05 | 2019-2024 | Venclose Maven Catheter |
| Medtronic, INC. | $102.69 | 2021 | |
| Baxter Healthcare | $80.60 | 2024 | Renal - Chronic |
| Argon Medical Devices, INC. | $44.79 | 2024-2025 | Clot Management, Clot Management |
| Covidien LP | $42.60 | 2019 | |
| Mozarc Medical US LLC | $35.91 | 2023-2025 | Palindrome, Chameleon |
| Cordis US Corp. | $32.49 | 2024 | Mynx Control |
| Abbott Laboratories | $24.53 | 2023 | Absolute Pro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rockey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.